← Eichor
Study identifier: NCT06707402 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Effects of 24-Weeks Community-based Brisk Walking in People With Parkinson's Disease

Condition: Parkinson Disease  ·  Sponsor: University of Aarhus

PhaseNA
Planned participants129
Who can joinAll sexes, 40 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to investigate if brisk walking can improve walking function in people with Parkinson's disease and what kind of brisk walking intervention that is most effective. The main questions are: If brisk walking can reduce self-perceived walking difficulty What type of exercise intervention is most effective. Researchers will compare a brisk walking group receiving a personalized walking program with a group receiving an activity tracker and a control group. Participants will * be tested at baseline (0 weeks), post the intervention period (24 weeks) and after a follow-up period (48 weeks). * be randomly allocated to one of three groups at baseline. * follow the prescribed intervention they are allocated to.

This description comes directly from the study's public registry record.

Talk to the study team

Frederik B Jensen, MSc  ·  +4521268252  ·  fbj@ph.au.dk

Ulrik Dalgas, Professor  ·  dalgas@ph.au.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Aarhus University, Department of Public Health, Sport ScienceAarhus C, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06707402